Hefei Lifeon Pharmaceutical Co., Ltd. (SHE:003020)
China · Delayed Price · Currency is CNY 17.39
+0.46 (2.72%)
Aug 4, 2026, 3:04 PM CST
SHE:003020 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,551 | 1,554 | 1,518 | 1,901 | 2,579 | 2,273 |
Revenue Growth | 0.36% | 2.33% | -20.11% | -26.31% | 13.46% | 20.01% |
Gross Profit Gross Profit Growth | 998.6 | 990.86 | 1,039 | 968.68 | 960.28 | 904.36 |
Operating Income Operating Income Growth | 132.64 | 134.72 | 152.19 | 205.85 | 194.78 | 172.36 |
Net Income Net Income Growth | 162.24 | 165.2 | 160.6 | 226.67 | 209.25 | 172.23 |
Earnings Per Share EPS Growth | 0.72 | 0.72 | 0.70 | 0.98 | 0.92 | 0.76 |
EPS Growth | -2.17% | 3.57% | -28.81% | 6.46% | 20.91% | -4.18% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Pharmaceutical Industry Pharmaceutical Industry Growth | 1,402 | 1,377 | 1,158 | 965.52 | 891.21 |
Pharmaceutical Retail Pharmaceutical Retail Growth | 113.28 | 110.53 | 134.39 | 129.69 | 95.59 |
Unallocated Other Business Income Unallocated Other Business Income Growth | 38.44 | 30.88 | 14.25 | 8.86 | 11.77 |
Total Total Growth | 1,554 | 1,518 | 1,901 | 2,579 | 2,273 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 485.59 | 454.16 | 508.36 | 564.45 | 642.7 | 654.39 |
Total Debt Total Debt Growth | 73.2 | 113.9 | 118.58 | 88.44 | 13.41 | 24.58 |
Net Cash (Debt) Net Cash Growth | 412.39 | 340.27 | 389.78 | 476 | 629.28 | 629.8 |
Net Cash Growth | 4.53% | -12.70% | -18.11% | -24.36% | -0.08% | -17.84% |
Net Cash Per Share Net Cash Per Share Growth | 1.82 | 1.49 | 1.70 | 2.06 | 2.78 | 2.79 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 240.49 | 212.89 | 197.53 | 203.67 | 200.64 | 158.7 |
Capital Expenditures CapEx Growth | -113.5 | -118.46 | -154.49 | -197.54 | -246.43 | -186.95 |
Free Cash Flow Free Cash Flow Growth | 127 | 94.43 | 43.05 | 6.14 | -45.79 | -28.24 |
Free Cash Flow Growth | 64.51% | 119.37% | 601.38% | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Gross Margin | 64.40% | 63.77% | 68.41% | 50.96% | 37.23% | 39.78% |
Operating Margin | 8.55% | 8.67% | 10.02% | 10.83% | 7.55% | 7.58% |
Pretax Margin | 11.54% | 11.70% | 11.31% | 13.54% | 9.30% | 8.57% |
Profit Margin | 10.46% | 10.63% | 10.58% | 11.92% | 8.11% | 7.58% |
FCF Margin | 8.19% | 6.08% | 2.83% | 0.32% | -1.77% | -1.24% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 4, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.417 | 0.417 | 0.417 | 0.347 | 0.267 | 0.288 |
Dividend Per Share Growth | 12.00% | 0% | 19.98% | 30.03% | -7.13% | 39.95% |
Dividend Yield | 2.46% | 1.96% | 2.90% | 1.90% | 1.67% | 1.67% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 4, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
PE Ratio | 24.25 | 29.80 | 21.52 | 19.83 | 18.90 | 24.67 |
Forward PE | - | 24.47 | 15.83 | 17.14 | 14.90 | - |
P/FCF Ratio | 31.25 | 52.12 | 80.29 | 732.38 | - | - |
PS Ratio | 2.56 | 3.17 | 2.28 | 2.37 | 1.53 | 1.87 |